-
[
International C. elegans Meeting,
1999]
How are introns and outrons recognized in C. elegans ? The 5' splice sites on introns are identified by base pairing with U1 snRNA, as they are in other animals. However, C. elegans introns lack both the polypyrimidine tract and the branchpoint consensus sequences found in other animals. Instead, they have a highly conserved 3' splice site octamer, U 4 CAG/R, that is required for both intron and outron recognition. In other animals, the polypyrimidine tract is bound by the two-subunit splicing factor, U2AF, but it has never been determined how the invariant AG at the 3' splice site is recognized. Here we report a probable solution to this problem for C. elegans . We have previously shown that C. elegans has both U2AF subunits and both are required for viability. We also showed that the large subunit gene contains an alternatively spliced exon containing multiple copies of the U 4 CAG/R consensus. We proposed that these octamers in the alternative exon serve as sites for autoregulation of U2AF levels by alternative splicing. To test whether U2AF does in fact bind to this consensus, we performed in vitro cross-linking experiments with crude embryo extracts from transgenic worms that overexpress both U2AF subunits in response to heat shock (with the small subunit epitope tagged). We then used immunoprecipitation to identify U2AF-cross-linked bands. We found that both subunits cross-link to an RNA oligonucleotide containing the complete consensus (U 4 CAG/G), but that only the large subunit cross-links to an RNA containing the 5 pyrimidines, but lacking the AG (U 4 CGAA). Furthermore, the presence of the AG-less RNA causes dissociation of the two subunits from each other. An RNA lacking 3 of the pyrimidines, but retaining the remainder of the consensus (UA 3 CAG/G), does not cross-link to either subunit. Our results suggest that U2AF small subunit may be responsible for recognition of the invariant AG at the 3' splice site, and that simultaneous recognition of the short polypyrimidine tract by U2AF large subunit and the AG/R by U2AF small subunit may be the key event in 3' splice site identification.
-
[
Biosci Biotechnol Biochem,
2016]
We compared the growth inhibitory effects of all aldohexose stereoisomers against the model animal Caenorhabditis elegans. Among the tested compounds, the rare sugars d-allose (d-All), d-talose (d-Tal), and l-idose (l-Ido) showed considerable growth inhibition under both monoxenic and axenic culture conditions. 6-Deoxy-d-All had no effect on growth, which suggests that C6-phosphorylation by hexokinase is essential for inhibition by d-All.
-
[
Bioorg Med Chem Lett,
2016]
Biological activities of unusual monosaccharides (rare sugars) have largely remained unstudied until recently. We compared the growth inhibitory effects of aldohexose stereoisomers against the animal model Caenorhabditis elegans cultured in monoxenic conditions with Escherichia coli as food. Among these stereoisomers, the rare sugar d-arabinose (d-Ara) showed particularly strong growth inhibition. The IC50 value for d-Ara was estimated to be 7.5mM, which surpassed that of the potent glycolytic inhibitor 2-deoxy-d-glucose (19.5mM) used as a positive control. The inhibitory effect of d-Ara was also observed in animals cultured in axenic conditions using a chemically defined medium; this excluded the possible influence of E. coli. To our knowledge, this is the first report of biological activity of d-Ara. The d-Ara-induced inhibition was recovered by adding either d-ribose or d-fructose, but not d-glucose. These findings suggest that the inhibition could be induced by multiple mechanisms, for example, disturbance of d-ribose and d-fructose metabolism.
-
[
Bioorg Med Chem Lett,
2019]
The biological activities of deoxy sugars (deoxy monosaccharides) have remained largely unstudied until recently. We compared the growth inhibition by all 1-deoxyketohexoses using the animal model Caenorhabditis elegans. Among the eight stereoisomers, 1-deoxy-d-allulose (1d-d-Alu) showed particularly strong growth inhibition. The 50% inhibition of growth (GI<sub>50</sub>) concentration by 1d-d-Alu was estimated to be 5.4mM, which is approximately 10 times lower than that of d-allulose (52.7mM), and even lower than that of the potent glycolytic inhibitor, 2-deoxy-d-glucose (19.5mM), implying that 1d-d-Alu has a strong growth inhibition. In contrast, 5-deoxy- and 6-deoxy-d-allulose showed no growth inhibition of C. elegans. The inhibition by 1d-d-Alu was alleviated by the addition of d-ribose or d-fructose. Our findings suggest that 1d-d-Alu-mediated growth inhibition could be induced by the imbalance in d-ribose metabolism. To our knowledge, this is the first report of biological activity of 1d-d-Alu which may be considered as an antimetabolite drug candidate.
-
[
Biochim Biophys Acta Proteins Proteom,
2020]
d-Aspartate oxidase (DDO) is a flavin adenine dinucleotide (FAD)-containing flavoprotein that stereospecifically acts on acidic D-amino acids (i.e., free d-aspartate and D-glutamate). Mammalian DDO, which exhibits higher activity toward d-aspartate than D-glutamate, is presumed to regulate levels of d-aspartate in the body and is not thought to degrade D-glutamate in vivo. By contrast, three DDO isoforms are present in the nematode Caenorhabditis elegans, DDO-1, DDO-2, and DDO-3, all of which exhibit substantial activity toward D-glutamate as well as d-aspartate. In this study, we optimized the Escherichia coli culture conditions for production of recombinant C. elegans DDO-1, purified the protein, and showed that it is a flavoprotein with a noncovalently but tightly attached FAD. Furthermore, C. elegans DDO-1, but not mammalian (rat) DDO, efficiently and selectively degraded D-glutamate in addition to d-aspartate, even in the presence of various other amino acids. Thus, C. elegans DDO-1 might be a useful tool for determining these acidic D-amino acids in biological samples.
-
[
J Appl Glycosci (1999),
2019]
D-Allose (D-All), C-3 epimer of D-glucose, is a rare sugar known to suppress reactive oxygen species generation and prevent hypertension. We previously reported that D-allulose, a structural isomer of D-All, prolongs the lifespan of the nematode Caenorhabditis elegans. Thus, D-All was predicted to affect longevity. In this study, we provide the first empirical evidence that D-All extends the lifespan of C. elegans. Lifespan assays revealed that a lifespan extension was induced by 28 mM D-All. In particular, a lifespan extension of 23.8 % was achieved (p< 0.0001). We further revealed that the effects of D-All on lifespan were dependent on the insulin gene
daf-16 and the longevity gene
sir-2.1, indicating a distinct mechanism from those of other hexoses, such as D-allulose, with previously reported antiaging effects.
-
[
J Nat Med,
2008]
No anthelmintic sugars have yet been identified. Eight ketohexose stereoisomers (D- and L-forms of psicose, fructose, tagatose and sorbose), along with D-galactose and D-glucose, were examined for potency against L1 stage Caenorhabditis elegans fed Escherichia coli. Of the sugars, D-psicose specifically inhibited the motility, growth and reproductive maturity of the L1 stage. D-Psicose probably interferes with the nematode nutrition. The present results suggest that D-psicose, one of the rare sugars, is a potential anthelmintic.
-
[
International C. elegans Meeting,
1999]
U2AF 65 is an essential splicing factor that recognizes the 3' splice site (UUUUCAG/R) in C. elegans ; its production is controlled by alternative splicing in a novel way. The 1.7 kb product that lacks exon 3 encodes U2AF 65 , whereas the 1.9 kb RNA, containing exon 3, is not a functional mRNA. It contains a premature stop codon, yet makes no detectable truncated protein. Although we expected that the relatively low levels of the 1.9 kb RNA could be due to Smg RNA surveillance, its level did not increase in
smg-2 mutants. We hypothesized that the Smg machinery, which recognizes premature stop codons in the cytoplasm, would not be able to detect and degrade the 1.9 kb RNA if it remained nuclear. Exon 3 contains 10 repeats of the UUUUCAG/R octamer; these could be responsible for preventing transport out of the nucleus by binding U2AF without any subsequent splicing. The net effect of such a mechanism could be down-regulation of U2AF 65 levels by accumulation of this product in the nucleus. To test this idea, we studied the expression in transgenic worms of a vit/gfp reporter with exon 3 inserted into its 3'UTR (gfpex3). Even though correctly spliced and polyadenylated intestinal gfpex3 mRNA levels were high, GFP was almost undetectable. Furthermore, in situ hybridization demonstrated dramatically that while control vit/gfp mRNA was cytoplasmic, the gfpex3 mRNA was almost entirely nuclear. If U2AF itself binds to the octamer repeats in exon 3 to prevent transport, a reduction in U2AF levels should allow the release of some mRNA, and thus an increase in GFP levels. We used RNAi to reduce U2AF levels in the intestines of injected worms and found a small burst of GFP in these animals. We conclude that U2AF binding of exon 3 prevents the gfpex3 mRNA from leaving the nucleus. U2AF 65 could autoregulate similarly by binding to exon 3 of its own pre-mRNA, causing inclusion of this exon. It could then remain bound to the 1.9 kb alternatively spliced product, and keep it in the nucleus to serve as a source of U2AF when the need arises.
-
Yousuke Seida, Kazuhiro Maeda, Tomonori Kawata, Masumi Katane, Hiroyuki Kobuna, Takao Inoue, Yasuaki Saitoh, Hiroyuki Arai, Yasuhito Nakagawa, Masae Sekine, Taro Sakamoto, Hiroshi Homma, Takemitsu Furuchi
[
East Asia Worm Meeting,
2010]
Among free D-amino acids existing in living organisms, D-serine (D-Ser) and D-aspartate (D-Asp) are the most actively studied. D-Ser has been proposed as a neuromodulator that regulates L-glutamate-mediated activation of the N-methyl-D-Asp (NMDA) receptor by acting as a co-agonist. On the other hand, several lines of evidence suggest that D-Asp plays important roles in regulating developmental processes, hormone secretion and steroidogenesis. D-Amino acid oxidase (DAO) and D-Asp oxidase (DDO) are known as stereospecific degradative enzymes that catalyze the oxidative deamination of D-amino acids. DAO displays broad substrate specificity and acts on several neutral and basic D-amino acids, while DDO is highly specific for acidic D-amino acids. DAO and DDO are presumed to regulate endogenous D-Ser and D-Asp levels, respectively, as well as mediate the elimination of accumulated exogenous D-amino acids in various organs. Previously, we demonstrated that nematode Caenorhabditis elegans, a multicellular model animal has at least one active DAO gene and three active DDO genes, while it had been thought that most organisms bear only one copy of each DAO and DDO gene. In addition, our previous study revealed that the spatiotemporal distributions of these enzymes in the body of C. elegans are different from one another. In this study, to elucidate the physiological roles of the C. elegans DAO and DDOs, we characterized several phenotypes of four C. elegans mutants in which each gene is partially deleted and inactivated. We also determined free D-amino acid contents in several worm samples using high-performance liquid chromatography (HPLC) techniques. We will report the phenotypes of the C. elegans mutants in comparison with those of wild-type C. elegans, as well as alterations in D-amino acid levels within the body.
-
Inoue, Takao, Sekine, Masae, Saitoh, Yasuaki, Arai, Hiroyuki, Furuchi, Takemitsu, Sakamoto, Taro, Okutsu, Mari, Homma, Hiroshi, Katane, Masumi
[
International Worm Meeting,
2013]
Among free D-amino acids existing in living organisms, D-serine (D-Ser) and D-aspartate (D-Asp) are the most intensively studied. In mammals, D-Ser has been proposed as a neuromodulator that regulates L-glutamate (L-Glu)-mediated activation of the N-methyl-D-Asp (NMDA) receptor by acting as a co-agonist. On the other hand, several lines of evidence suggest that D-Asp plays important roles in regulating hormone secretion and steroidogenesis. D-Amino acid oxidase (DAO) and D-Asp oxidase (DDO) are known as stereospecific degradative enzymes that catalyze the oxidative deamination of D-amino acids. Mammalian DAO and DDO are presumed to regulate endogenous D-Ser and D-Asp levels, respectively. Previously, we demonstrated that D-Ser, D-Asp, D-Glu and D-alanine (D-Ala) are present in nematode Caenorhabditis elegans, a multicellular model animal. We also found that C. elegans has at least one active DAO gene and three active DDO genes (DDO-1, DDO-2 and DDO-3), and that the spatiotemporal distributions of these enzymes in the body of C. elegans differ from one another. Furthermore, our previous study showed that alterations of brood size and hatching rate are observed in four C. elegans mutants lacking each gene for the DAO and DDOs. Interestingly, lifespan extension was observed in the DDO-3 mutant. To characterize the mechanism of lifespan extension in the DDO-3 mutant, we performed genetic epistasis experiments to test interactions between the DDO-3 gene and other known longevity pathways. The results suggest that DDO-3 is involved in caloric restriction-induced lifespan extension but not in insulin/IGF signaling pathway, NAD/sir2 pathway nor mitochondrial electron transport system. We also found that D-Glu and L-tryptophan (L-Trp) accumulate throughout life in the DDO-3 mutant. Now we are investigating the relationship between aging and the accumulations of D-Glu and L-Trp.